STEROID COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS WITH NERVOUS DISORDERS (VARIANTS) AND METHOD OF ANESTHESIA INDUCTION IN ANIMAL Russian patent published in 2001 - IPC

Abstract RU 2176248 C2

FIELD: organic chemistry, steroids, pharmacy. SUBSTANCE: invention describes steroid compounds of the general formula (I) where: a) R4 means 3'-methyl-but-3'-ene-1'-inyl or cyclopro-pylethynyl; R5 means methyl; R6 means acetyl; dotted line means a single bond; b) R4 means trifluoromethyl-group; R5 means methyl; R6 means acetyl; dotted line means a single or a double bond and in the case when this bond is a single one, R6 is hydroxyacetyl and R5 is hydrogen atom then R4 can mean fluoromethyl-group; c) R4- means ethynyl; R5 means methyl; R6 means hydroxymethyl or hydroxyacetyl; dotted line means a single bond, or their physiologically acceptable 21-esters, 3,20-diesters or 3,21-diesters or where: a) R6 means hydroxyacetyl; R5 means hydrogen atom in the case when R4 is trifluoromethyl-group and compound is presented as sodium 21-hemisuccinate; b) R6 means hydroxyacetyl; R5 means methyl and R4 can mean the following values: hydrogen atom in the case when compound is presented as bis-hemisuccinate; ethynyl in the case of 21-hemisuccinate; trifluoromethyl-group in the case of sodium 21-hemifumarate, methyl-21-succinate, 21-propionate; and c) R4 means methyl; R5 means methyl; R6 means isopropylideneaminoethanol being dotted line means a single bond. Compounds of the formula (I) show ability to modulate excitability of GRC complex and therefore they can be used for treatment of patients with stresses, anxiety state, epileptic attack, mood disorders, premenstrual syndrome and post-delivery depression and for induction of anesthesia also. EFFECT: improved method of treatment and induction, valuable medicinal properties. 15 cl, 8 tbl, 31 ex

Similar patents RU2176248C2

Title Year Author Number
NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE 1996
  • Lehn Nensi K.
  • Fik Dehvid B.
  • Khogenkehmr Derk Dzh.
  • Jupehzehnaj Rehjvindra B.
RU2194712C2
NEW STEROID COMPOUNDS SHOWING HIGHER WATER SOLUBILITY AND METABOLISM RESISTANCE, AND METHODS FOR PREPARING THEM 2007
  • Behkstrem Torb'Ern
  • Ragagnin Dzhinna
RU2458065C2
3α-ETHYNYL, 3β-HYDROXY, 5α-PREGNAN-20-OXIME FOR USE IN TREATING CNS DISORDERS 2016
  • Ragagnin Gianna
  • Backstrom Torbjorn
RU2712786C2
ORGANIC COMPOUNDS 2019
  • Vanover, Kimberly
  • Li, Peng
  • Davis, Robert
  • Qiao, Yupu
RU2809023C2
DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING 1995
  • Gebkhar Ronal'D
  • Van Der Vort Khendrikus Adrianus Antonius
RU2152952C2
METHOD OF PRODUCING 3β-ACETOXY-17α-HYDROPEROXY-16α-METHYLPREGNANES FROM Δ-20-KETOSTEROIDS AND METHOD OF PRODUCING 3β-ACETOXY-17α-HYDROXY-16α-METHYLPREGNANES USING 3β-ACETOXY-17α-HYDROPEROXY-16α-METHYLPREGNANES 2009
  • Savinova Tat'Jana Stepanovna
  • Lukashev Nikolaj Vadimovich
  • Beletskaja Irina Petrovna
RU2418805C1
METHOD OF STEREO-SPECIFIC REDUCTION OF SAPOGENINE-3 2003
  • Ganning Filip Dzhejms
  • Tiffin Peter Dehvid
RU2326890C2
ANDROSTANES 1995
  • Dehvid L. Berliner
  • Natan V. Adams
  • Kliv L. Dzhennings-Vajt
RU2160740C2
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT 1994
  • Behchelor Kennet Uil'Jam
  • Fraj Stiven Vernon
RU2144037C1
DERIVATIVES OF 19-NORPREGNENE, PHARMACEUTICAL COMPOSITION, COMPOUNDS 1997
  • Alan Piasko
  • Zhan Ljafaj
  • Remi Delansorn
  • Zhak Pari
  • Zhan-Klod Paskal'
RU2166509C2

RU 2 176 248 C2

Authors

Boldzhehr Majkl B.

Gi Kelvin U.

Lehn Nensi K.

Pehrdi Robert

Takhir Khasan

Jupehzehnaj Rehjvindra B.

Dates

2001-11-27Published

1995-11-22Filed